.png){kind=icon}
.png){kind=icon}
Return
Inhibition of the Serotonin Transporter and Risk of Heart Valve Disease: A Systematic Review and Meta-Analysis
.png){kind=icon}
PRE
AI
A
A
E
Y
C
D
R
J
R
G
DOI：10.1016/j.ejphar.2026.178954.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Serotonin transporter inhibition disrupts heart valve physiology • Meta-analysis associates use of SERT-inhibitors with heart valve dysfunction • Mechanistic study of heart valve disease linked to SERT-inhibition remains limited • Risk-based screening may lead to safer prescribing strategies
Keywords:
Serotonin transporter inhibition
Heart valve disease
Meta-analysis
SERT-inhibitors
Risk-based screening
Journal
IF:
4.7
Papers:
2.3W
Citations:
4.0W
Organization
Cited Papers